Dr Maziar Rahmani, M.D., Ph.D., DABIM

Clinical Fellow, Endocrinology and Metabolism, National Institutes of Health

How does this work?

Maziar Rahmani, M.D., Ph.D., DABIM, is an adult endocrinology fellow in NIH’s Inter-Institute Endocrinology Training Program. During medical school in Iran, he founded a lipid research clinic and conducted several randomized clinical trials on high risk populations. This work was recognized by the International College of Angiology, which awarded him the Young Investigator Award for his role as a lead investigator early during his medical career. Following his internship, he received a fellowship from the Research Institute for Endocrine Sciences (RIES) in Iran and investigated trends in cardiometabolic diseases among 15,000 individuals, one of the largest cohort studies conducted in Asia, resulting in multiple peer-reviewed publications on which he was lead or co-author. Subsequently, to build on this solid foundation of work in both the clinical and research arenas, Dr. Rahmani joined the Center for Heart Lung Innovation at the University of British Columbia in Vancouver of Canada as a PhD trainee investigating the molecular mechanism of genes in cardiovascular disease. This work also resulted in numerous peer-reviewed publications. He discovered that proteoglycan versican transcription is mediated by Wnt/beta-catenin transcription factor and the androgen receptor complex in vascular smooth muscle cells, wherein such regulation contributes to the normal or aberrant vascular injury and repair events. His work earned him two research fellowship awards, from the Michael Smith Foundation for Health Research and the Heart and Stroke Foundation of Canada/Pfizer, which allowed him to pursue his postdoctoral fellowship at the Genome Sciences Center (GSC) in Vancouver. At GSC, he continued his investigations of several complex genetic traits, including age at natural menopause and autoimmune thyroid disease, which then led to the identification of several novel genetic variants and associated genes. Dr. Rahmani currently studies diabetic vascular disease in Dr. Brant Weinstein’s lab at NICHD, exploring whether short-term exposure to hyperglycemia in vivo causes long-term epigenetic changes in vasculature. The overarching objective of this work is to investigate genome-wide epigenomics and transcriptomics of glycemic memory in vascular wall cells. Dr. Rahmani completed an internal medicine residency at the George Washington University and is board certified in internal medicine by the American Board of Internal Medicine.

Work experience

Jul 2018 - Present

National Institutes of Health (NIH): Intramural Research Program (IRP)

Clinical Fellow

Jul 2017 - Present

Johns Hopkins Hospital

Elective Resident Physician Rotation

I have attended the elective rotation in the Division of Endocrinology, Diabetes and Metabolism in the Johns Hopkins Hospital. I have had the opportunity to rotate in the endocrinology specialty clinics including general endocrine, pituitary, adrenal, gonad, thyroid, diabetes, and lipodystrophy. I will also participate in several weekly conferences during this rotation.

Jul 2015 - Present

Providence Hospital (Providence Health System)

Resident Physician

Providence Hospital, Internal Medicine Residency Program affiliated to George Washington University Hospital, Washington, DC

Mar 2017 - Apr 2017

Johns Hopkins Hospital

Elective Resident Physician Rotation

I participated at lipid clinic at Johns Hopkins Hospital. I also participated in the general cardiology attending rounds responsible for management of assigned patients. I also regularly participated in several departmental conferences during this elective.


Jan 2016 - Dec 2016

The George Washington University Hospital

Elective Resident Physician Rotation in Cardiology

Board Certified

Talk to Maziar

@ Copyright 2020 OfficeHours Technologies Co.